Uncaria rhynchophylla
Alzheimer’s disease is characterized by the accumulation of beta-amyloid protein deposits in the brain. Research published in the Journal of Neuroscience Research (August 1, 2006; Vol. 84, Issue 2, pp. 427–433) examined the effects of the Chinese herb Uncaria rhynchophylla on beta-amyloid formation.
In laboratory models, compounds from Uncaria rhynchophylla inhibited beta-amyloid fibril formation—an early step in plaque development. By interfering with this process, the herb demonstrated a potential to reduce beta-amyloid aggregation. The authors suggested that these properties could be relevant to slowing disease progression or reducing amyloid burden, though clinical studies would be required to confirm this effect in humans.
The herb contains several bioactive compounds, including oxindole and indole alkaloids, which are thought to exert neuroprotective effects. Notably, these include rhynchophylline and geissoschizine methyl ether (GME), both of which have demonstrated activity in nervous system signaling pathways.
Uncaria rhynchophylla (not to be confused with Uncaria tomentosa) has a long history of use in traditional East Asian medicine for conditions such as hypertension, convulsive disorders, dizziness, and headache. It is also a component of the Japanese herbal formula Yokukansan, where it appears to contribute to the formula’s neuroprotective and calming effects, particularly when combined with licorice (Glycyrrhiza uralensis).
